Combination therapies for HIV infection and genomic drug resistance
Katzenstein, D.
Lancet 350(9083): 970-971
1997
ISSN/ISBN: 0140-6736 PMID: 9329506 Document Number: 481098
This article consists of general and specific comments on the Delta trial of combination nucleoside analogue therapy versus monotherapy against HIV infection (see also Brun-Vezinet et al. Lancet (1997) 350 983).
Document emailed within 1 workday
Related Documents
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836Farlow, M.R. 2005: Combination drug therapies for AD: progress is slow, but we must keep trying Geriatrics 60(6): 13-14
Ying, H.-c.; Zhang, S.-l.; Jiang, T.; Ouyang, L.; Lü, J. 2007: Mechanisms of drug resistance in human ovarian carcinoma studied by comparative genomic hybridization Zhonghua Yi Xue Za Zhi 87(15): 1009-1012
Sonoo, H.; Senoo, T.; Nishiki, M.; Morimoto, T.; Takashima, S. 1996: Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(4): 447-454
Wang, F. 2006: To enhance the research of antibiotic resistance and infection caused by drug-resistance bacteria Zhonghua Yi Xue Za Zhi 86(9): 579-580
Ssemwanga, D.; Ndembi, N.; Lyagoba, F.; Magambo, B.; Kapaata, A.; Bukenya, J.; Lubega, G.W.; Bertagnolio, S.; Vandepitte, J.; Grosskurth, H.; Kaleebu, P. 2012: Transmitted antiretroviral drug resistance among drug-naive female sex workers with recent infection in Kampala, Uganda Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S339-S342
Zhou, Y.Q.; Ning, D.X. 1988: Inhibitory effect of artemisinine-sulfadoxine-pyrimethamine combination on the development of drug-resistance in Plasmodium berghei Zhongguo Yao Li Xue Bao 9(5): 453-457
Di Giambenedetto, S.; Zazzi, M.; Corsi, P.; Gonnelli, A.; Di Pietro, M.; Giacometti, A.; Almi, P.; Trezzi, M.; Boeri, E.; Gianotti, N.; Menzo, S.; Del Gobbo, R.; Francisci, D.; Nerli, A.; Galli, L.; De Luca, A. 2009: Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy Antiviral Therapy 14(3): 359-369
Bhasin, D.K.; Sharma, B.C.; Ray, P. 2000: Drug resistance in Helicobacter pylori infection Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 19(Suppl): S29-S32
Xu, J.-J.; Qian, H.-Z.; Chu, Z.-X.; Zhang, J.; Hu, Q.-H.; Jiang, Y.-J.; Geng, W.-Q.; Zhang, C.M.; Shang, H. 2014: Recreational drug use among Chinese men who have sex with men: a risky combination with unprotected sex for acquiring HIV infection Biomed Research International 2014: 725361
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
Walia, S.K.; Chugh, T.D. 1979: Transmissible drug resistance among Klebsiella species in urinary tract infection Indian Journal of Pathology and Microbiology 22(2): 153-157
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355
Bertagnolio, S.; Rodriguez-Diaz, R.A.; Fuentes-Romero, L.L.; Bennett, D.E.; Viveros-Rogel, M.; Hart, S.; Pilon, R.; Sandstrom, P.; Soto-Ramirez, L.E. 2012: Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S328-S333
Price, M.A.; Wallis, C.L.; Lakhi, S.; Karita, E.; Kamali, A.; Anzala, O.; Sanders, E.J.; Bekker, L.-G.; Twesigye, R.; Hunter, E.; Kaleebu, P.; Kayitenkore, K.; Allen, S.; Ruzagira, E.; Mwangome, M.; Mutua, G.; Amornkul, P.N.; Stevens, G.; Pond, S.L.K.; Schaefer, M.; Papathanasopoulos, M.A.; Stevens, W.; Gilmour, J. 2011: Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa Aids Research and Human Retroviruses 27(1): 5-12
Salomon, H.E.; Pampuro, S.E.; Gu, Z.; Montaner, J.S.; Libonatti, O.; Wainberg, M.A. 1995: Basic and clinical aspects of drug resistance in human immunodeficiency virus type 1 infection Revista Argentina de Microbiologia 27(4): 214-229
Towler, W.I.; Barlow-Mosha, L.; Church, J.D.; Bagenda, D.; Ajuna, P.; Mubiru, M.; Musoke, P.; Eshleman, S.H. 2010: Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda Aids Research and Human Retroviruses 26(5): 563-568
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285
Hirsch, M.S.; Brun-Vézinet, F.; D'Aquila, R.T.; Hammer, S.M.; Johnson, V.A.; Kuritzkes, D.R.; Loveday, C.; Mellors, J.W.; Clotet, B.; Conway, B.; Demeter, L.M.; Vella, S.; Jacobsen, D.M.; Richman, D.D. 2000: Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel JAMA 283(18): 2417-2426